| Literature DB >> 32319951 |
Ikbel Ghachem1, Wijdène El Borgi2, Sarra Fekih Salem3, Fatma Ben Lakhal2, Amel Chelbi4, Iheb Ghiriani5, Emna Gouider2.
Abstract
Factor V deficiency is a rare hemostatic disorder. It may present with a diverse spectrum of symptoms due to a variety of mechanisms including development of autoantibodies associated with a number of conditions. We report a first case of factor V deficiency in Tunisian hemodialysis patient due to an autoantibody most likely secondary to antibiotic exposure responsible for an arteriovenous shunt thrombosis rather than bleeding. We discuss here the clinical and biological features of acquired factor V inhibitor and provide a short review of the current literature.Entities:
Keywords: acquired factor V inhibitor; biological tests; haemodialysis; thrombosis
Mesh:
Substances:
Year: 2020 PMID: 32319951 DOI: 10.1684/abc.2020.1540
Source DB: PubMed Journal: Ann Biol Clin (Paris) ISSN: 0003-3898 Impact factor: 0.459